Research Library

Browse, search, and filter the complete database of verified scientific literature

5 results for “neuroprotection
Year:
Showing 5 of 155 articles

Filters

Year:
Pharmacology
NewDOI Resolved

Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells

Salles G, de Carvalho Alves I, de Assis Braz G et al.
Archives of Toxicology, 2025
Preclinical in vitro
Pharmacology
NewPubMed Verified

Ayahuasca pretreatment prevents sepsis-induced anxiety-like behavior, neuroinflammation, and oxidative stress, and increases brain-derived neurotrophic factor

da Silva FS, Silva EAS, Sousa GM et al.
Journal of Psychiatric Research, 2023
15 citations
Preclinical in vivo
Neuroscience
NewPublisher Confirmed

Preliminary analysis of ayahuasca-induced anatomical alterations in the somatosensory cortex of juvenile non-human primates subjected to chronic stress

Fernandes Pereira LR, Lira-Bandeira WG, Medeiros-Bandeira AS et al.
Translational Psychiatry, 2026
Open Access
Preclinical / in vivo
Pharmacology
NewPubMed Verified

Neuroprotective potential of ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease

Katchborian-Neto A, Santos MFC, Nicacio KJ et al.
Journal of Ethnopharmacology, 2020
75 citations
Preclinical in vitro
Pharmacology
NewPubMed Verified

The endogenous hallucinogen and trace amine N,N-dimethyltryptamine displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells

Szabo A, Kovacs A, Riba J et al.
Frontiers in Neuroscience, 2016
200 citationsOpen Access
Preclinical in vitro